In recognition of the need for alternatives to injectable drugs, ~44% of drug candidates are intended for oral delivery, either exclusively, or as an alternative to another mode of delivery, (Figure 3 d)
It reduces appetite, helps control cravings, and increases calorie burn by modulating neurotransmitters in the brain
Its worth noting that much of AOD-9604s proposed functionality stems from early animal and lab studies
It's your own biology, amplified and delivered exactly where your body needs it most
Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, et al
More high-quality research is needed before DSIP can be recommended as a standard sleep treatment